-DigiTimes Report
Citigroup Maintains Neutral on Sensata Technologies, Lowers Price Target to $42
Citigroup analyst Jim Suva maintains Sensata Technologies (NYSE:ST) with a Neutral and lowers the price target from $45 to $42.
Related Posts
Top Cannabis Movers For October 5, 2021
GAINERS:
Tetra Bio Pharma (OTC:TBPMF) shares closed up 21.96% at $0.22 with an estimated market cap of $88.1M.
SVB Leerink Maintains Outperform on Theravance Biopharma, Lowers Price Target to $36
SVB Leerink analyst Geoffrey Porges maintains Theravance Biopharma (NASDAQ:TBPH) with a Outperform and lowers the price target from $39 to $36.
